Bortezomib 2mg
In stock
Description
Bortrac 2 mg Injection (Bortezomib IP) is an anti-cancer medication containing 2 mg of the active salt bortezomib per vial, manufactured by Glenmark Pharmaceuticals. It is primarily used to treat multiple myeloma and mantle cell lymphoma.

